Molecular Assemblies

Reinventing DNA synthesis for gene editing and gene assembly experiments

First Investment: 2015

Synthetic DNA is an important emerging tool in clinical medicine, pharmaceuticals, agriculture, and food. Yet research is being held back by traditional DNA synthesis techniques, which can produce only short segments of DNA. Molecular Assemblies has created an evolved polymerase enzyme that can rapidly synthesize ultra-long oligonucleotide chains with 150 or more nucleotide bases. The enzyme also eliminates the time required for purification by weeding out incomplete oligos as it goes.

Explore Companies

Syntax Bio

Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics

Using state-of-the-art machine learning models to create custom-build protein drugs

Nilo Therapeutics

Mapping the brain-body axis to achieve proper immune balance

Avicenna Biosciences

Using AI to speed through the last mile of drug discovery